KCM
AMAG

Kingdon Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Kingdon Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-145,474
Closed -$5.06M – 155
2016
Q4 		$5.06M Sell
145,474
-127,052
-47% -$3.8M 0.24% 93
2016
Q3 		$6.68M Buy
+272,526
New +$6.81M 0.31% 74
2015
Q2 		– Sell
-209,017
Closed -$11.4M – 171
2015
Q1 		$11.4M Sell
209,017
-209,016
-50% -$9.96M 0.48% 61
2014
Q4 		$17.2M Buy
+418,033
New +$15.1M 0.75% 41

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kingdon Capital Management's AMAG Position: Q1 2017 in Review

Kingdon Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 145,474 shares — an estimated $5.06M sold.

Kingdon Capital Management first reported a position in AMAG in Q4 2014 and held it in 4 quarters. The position peaked at $17.2M in Q4 2014. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Kingdon Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Kingdon Capital Management sold 145,474 AMAG Pharmaceuticals shares in Q1 2017, an estimated $5.06M.
  • Kingdon Capital Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Kingdon Capital Management's AMAG Pharmaceuticals position peaked at $17.2M in Q4 2014.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Kingdon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.